Newormics vivoChips are designed to work with the vivoCube microfluidics control unit. The vivoCube provides simple push-button operation and allows rapid loading, alignment and immobilization of animals within vivoChips .
We now offer two simple and flexible rental plans for our systems, allowing you to use vivoChips and vivoCube in your lab for an extended time without the up-front cost of immediate purchase of the vivoCube. These plans can allow scientists to take advantage of our rapid immobilization and imaging technology for C. elegans straight away, acquire data for publications and grants, and fully evaluate our technology's capabilities before making a decision to purchase a complete package.
With the Monthly rental plan, you simply pay a monthly rental fee and use the vivoCube for up to 6 months.
With the Rent-to-own plan, you also pay a monthly rental fee, but have the option to own your vivoCube system outright at any time by paying the difference between what you have already paid in rental fees and the original list price of the vivoCube.
Under Monthly Rental Plan, maximum period for renting the vivoCube is 6 months from the starting date of the contract. Total * Additional payment processing fees apply.
Under Monthly Rent to Own Plan, customers will have the option to own their vivoCube® system outright at any point during the rental period by paying the difference between rental fees paid to date, and the original list price of the vivoCube®. Total * Additional payment processing fees apply.Monthly rental plan
Monthly vivoCube® rental periods
Rental fee
Running
1st month
$ 649.00
$ 649.00
2nd month
$ 446.00
$ 1,095.00
3rd month
$ 446.00
$ 1,541
4th month
$ 446.00
$ 1,987.00
5th month
$ 446.00
$ 2,433.00
6th month
$ 446.00
$ 2,879.00
Rent-to-own plan
Monthly vivoCube® rental periods
Rental fee*
Running
1st month
$ 945.00
$ 945.00
2nd month
$ 749.00
$ 1,694.00
3rd month
$ 749.00
$ 2,433.00
4th month
$ 749.00
$ 3,192.00
5th month
$ 749.00
$ 3,941.00
6th month
$ 749.00
$ 4,690.00
Under both plans, customer must purchase at least 1 set of vivoChips and a starter kit containing the tools and accessories needed to run experiments with the vivoCube. Shipping and handling not included.
Terms and conditions apply.
A professor with dual appointments in Mechanical Engineering and Biomedical Engineering at The University of Texas at Austin, Dr Ben-Yakar’s research focuses on the creation of imaging technologies and novel laser surgery with high precision. Educated at Stanford and the Technion in Israel, with post-doctoral study at Harvard, and using her NIH Director’s Transformative Research Award, Dr Ben-Yakar began the research that has culminated in the launch of Newormics, LLC
Contact us for more information on our products and services.
Evan Hegarty, co-founder, received his M.S. in Mechanical Engineering at The University of Texas at Austin while developing the technology and IP that lead to the launch of Newormics, LLC. As the Director of Manufacturing and Product development, and Principal Investigator of NIH SBIR grants at Newormics, Evan is responsible for development of all chip and system designs, creating production schedules, optimizing production methods, managing team members, identifying customer needs, developing future products, and reinforcing GLP and GMP.
Dr. Yunki Im is a molecular geneticist with expertise in autophagy, mitophagy, unfolded protein response, post-translational modifications (sumoylation and ubiquitination), and mitochondrial biology applied to study neurodegenerative disease and cardiac vascular disease in C. elegans and mice. He was educated at GIST in Korea, with post-doctoral study at University of Rochester, NY.
Jacob Moore completed his master’s and PhD in mechanical engineering at the University of Texas at Austin before joining the Newormics team. From his experimental research in the gas turbine industry, he developed a hands-on expertise in thermal/fluids systems that he is applying to chip and system designs. In addition, he is using his automated laboratory measurement experience to mature automation designs using Newormics technology.
Dr. Adam Laing is a molecular and cellular biologist educated at the University of Edinburgh, and leads the Research and Development activities of Newormics. He is responsible for testing and characterizing the new devices and imaging methods, and development of toxicology and drug screening assays in C. elegans as well as tissue organoids.
Dr. Lento is a serial COO/VPO executive for life science startups with broad skills in pharmaceuticals, medical devices, and diagnostics. With a unique background of equal parts government, public and private sector service, Dr. Lento holds a PhD in Biochemistry and additional credentials in Drug Evaluation, Pharmaceutical Sciences, and Corporate Governance.